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Melioidosis is associated with significant mortality in countries in which it is endemic. Previous studies have
demonstrated that quantitative Burkholderia pseudomallei counts in blood are predictive of mortality. Here we
examine the relationship between outcomes and quantitative B. pseudomallei counts in urine. A total of 755
patients presenting to Sappasithiprasong Hospital, Ubon Ratchathani, northeast Thailand (in the northeast
part of the country), with melioidosis between July 1993 and October 2003 had quantitative urine cultures
performed within 72 h of admission. Urine culture results were divided into the following groups: (i) no growth
of B. pseudomallei from a neat sample or pellet, (ii) positive result from a centrifuged pellet only (<103
CFU/ml), (iii) detection of between 103 CFU/ml and 105 CFU/ml from a neat sample, or (iv) detection of >105
CFU/ml from a neat sample. The overall in-hospital mortality rate was 45%. Patients with negative urine
cultures had the lowest death rate (39%). Mortality rates rose with increasing B. pseudomallei counts in urine,
from 58% for those with positive spun pellets only to 61% for those with between 103 CFU/ml and 105 CFU/ml
and 71% for those with>105 CFU/ml. This was independent of age, presence of bacteremia, known risk factors
for melioidosis such as diabetes, and the prior administration of antibiotics. The presence of B. pseudomallei
in urine during systemic infection is associated with a poor prognosis.
Melioidosis, the disease caused by the gram-negative bacil-
lus Burkholderia pseudomallei, is associated with significant
mortality in countries in which it is endemic. The case fatality
rate is approximately 50% for Thai adults and 19% for patients
in northern Australia (2, 9). Delineating predictors of a poor
outcome following admission provide clinical tools with which
to identify high-risk patients. Previous studies have demon-
strated that the clinical severity (1), bacterial count in the
blood (8), and magnitude of the inflammatory response (6) are
predictive of mortality for patients with melioidosis. Defining
colony counts in blood is straightforward but is only applicable
to patients with positive blood cultures upon presentation
(50% of patients, in our experience) and is relatively expensive
for resource-poor regions of the world.
Quantitative urine culture is a standard, inexpensive diag-
nostic test that is widely undertaken to provide laboratory
evidence of urinary tract infection. The presence of 105
CFU/ml in urine culture is used to distinguish between a con-
taminated sample and one from a patient with urinary tract
sepsis and is generally accepted as the gold standard for lab-
oratory diagnosis (5). This interpretation is not applicable to
patients with suspected melioidosis. B. pseudomallei is not a
member of the human commensal flora, and the isolation of
even a single colony in urine is both significant and sufficient to
confirm the diagnosis of melioidosis. Furthermore, the signif-
icance of B. pseudomallei counts in urine is poorly understood.
Although the urinary tract may be the primary source (espe-
cially in nephrolithiasis) of the organism or may become in-
volved in the infective process, it is unclear whether the stan-
dard cutoff of 105 CFU/ml indicates an infection of the
bladder, kidneys, or prostate. For this study, we explored the
relationship between urinary symptoms and positive urine cul-
ture results for B. pseudomallei, determined whether the B.
pseudomallei count in urine represents a marker for mortality
risk, and defined the role of this simple, inexpensive technique
in the diagnosis of melioidosis.
MATERIALS AND METHODS
Patients were recruited prospectively between July 1993 and October 2003 by
a study team at Sappasithiprasong Hospital, Ubon Ratchathani, Thailand (lo-
cated in the northeastern part of the country). Patients with suspected melioid-
osis were actively sought during twice-daily rounds of the medical and intensive
care wards, together with passive surveillance of the surgical and pediatric wards
as a part of eligibility screening for clinical trials. Detailed clinical information,
including the treatment regimen, was recorded. Microbiological specimens for
blood culture and throat swabs were taken from all patients, and urine, pus, and
sputum were collected when available. All culture-proven melioidosis patients
who had urine cultures within 3 days of admission were enrolled in the study.
Urine was collected into a sterile container and transported immediately to
our on-site microbiology research laboratory. Using a sterile calibrated loop, we
streaked 1 l of fresh, unprocessed urine onto one half each of a MacConkey
agar plate and an Ashdown’s agar plate and then incubated the plates at 37°C for
2 days or 4 days, respectively. The remaining urine sample was centrifuged at
3,000 rpm for 5 min, excess supernatant was removed, and the pellet was cultured
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on one half of an Ashdown’s agar plate. B. pseudomallei was identified by
standard methodology as previously described (3).
For the purposes of analysis, urine culture results were divided into the
following four groups based on the presence and number of B. pseudomallei cells:
(i) no growth of B. pseudomallei from a neat sample or pellet, (ii) culture of B.
pseudomallei from the centrifuged pellet only (103 CFU/ml), (iii) detection of
between 103 CFU/ml and 105 CFU/ml, or (iv) detection of 105 CFU/ml in a
neat sample. Because renal tubular acidosis is endemic to this region, we spe-
cifically examined the profiles of a subgroup of patients with nondiabetic renal
disease. Statistical analysis was performed with the statistical program Inter-
cooled STATA, version 8.0 (College Station, Tex.). The trend across ordered
groups was tested with a 2 test for trend. Logistic regression analysis was used
to examine the independence of factors associated with quantitative urine cul-
tures and the prognostic value of quantitative urine cultures for the survival
outcome. Ethical approval for all clinical trials was obtained from the Ministry of
Public Health, Royal Government of Thailand.
RESULTS
During the 10-year study period, 1,950 patients were admit-
ted to Sappasithiprasong Hospital with culture-confirmed me-
lioidosis. Quantitative urine cultures were performed within
72 h of admission in 822 of these cases 230 (28%) of which
were positive for B. pseudomallei. Fifty-eight positive cases
were excluded because no record had been made of the quan-
titative urine culture results, and nine cases were subsequently
excluded because of missing outcome data. For the remaining
755 patients included in the study, the median age was 48 years
(range, 1 to 89 years), and 57% of the patients were male.
Diabetes (n  363; 48%) and renal disease, including chronic
renal failure and renal calculi (n  165; 22%), were common
comorbidities. Blood cultures were performed in 727 of the
755 cases, 487 (67%) of which were positive. The overall in-
hospital mortality rate was 45%.
Urine cultures that were positive for B. pseudomallei were
analyzed from 171 patients (23%). Of these, 52 (30%) were
positive from the spun pellet only (103 CFU/ml), 51 (30%)
contained between 103 CFU/ml and 105 CFU/ml, and 68
(40%) contained105 CFU/ml. The urine culture was the only
positive direct specimen in 70 cases. Nineteen of these (27%)
were culture positive from the spun pellet only, and eight of
these patients had negative blood cultures.
Positive urine cultures were significantly associated with in-
creasing age, the presence of urinary symptoms, preexisting
renal disease, and positive blood cultures upon both univariate
and multiple-variable analyses. For both of these models, pa-
tients with diabetes and those who had received antibiotics
which are active against B. pseudomallei prior to urine culture
had lower rates of urine culture positivity (Table 1). The same
factors predicted bacterial concentrations in the urine (data
not shown). Only 41 patients (24%) with positive urine cultures
had urinary symptoms.
The mortality rate rose with increasing bacterial quantities
in urine. For melioidosis patients with negative urine cultures,
the fatality rate was 39% (228 of 584 patients). In contrast,
patients with positive urine cultures from the spun pellet (103
CFU/ml) had a 58% mortality rate (30 of 52 patients), patients
with positive urine cultures with between 103 and 105 CFU/ml
had a 61% mortality rate (31 of 51 patients), and patients with
positive urine cultures with 105 CFU/ml had a 71% mortality
rate (48 of 68 patients).
In a multiple-variable model, a positive blood culture, a
clinical diagnosis of pneumonia, and age were significantly
associated with mortality, and diabetes and the prior adminis-
tration of an effective antibiotic regimen were associated with
survival. A positive urine culture was predictive of mortality
independent of the prior receipt of active antibiotics, age,
diabetes, blood culture positivity, and the presence of pneu-
monia. Furthermore, the magnitude of the urinary bacterial
concentration was correlated with an increased risk of mortal-
ity compared to that of patients with negative urine cultures
(2 test for trend; P  0.001) (Table 2).
There were 116 patients with nondiabetic renal disease.
These patients had a higher rate of positive urine cultures
(39% versus 20%; P  0.001) but a similar rate of blood
culture positivity (69% versus 64%; P  0.29) as patients with-
out renal disease. Nondiabetic renal disease was associated
with a higher mortality rate (65% versus 41%; P  0.001).
DISCUSSION
This study has demonstrated that the presence and number
of B. pseudomallei organisms in the urine of patients present-
ing with melioidosis have predictive value in terms of identi-
TABLE 1. Variables associated with positive urine cultures (n 
171) for 755 patients with melioidosisa
Variable No. ofpatients
Univariate odds
ratio (95% CI)
Multiple-variable
odds ratio (95% CI)
Age 1.01 (1.002, 1.02) 1.01 (1.001, 1.02)
Diabetes 363 0.49 (0.34, 0.69) 0.54 (0.38, 0.80)
Urinary symptomsb 123 1.9 (1.3, 2.9) 1.7 (1.1, 2.7)
Prior administration of
active antibioticsc
161 0.42 (0.25, 0.69) 0.51 (0.31, 0.87)
Preexisting renal
disease
165 2.1 (1.5, 3.1) 1.6 (1.1, 2.4)
Positive blood culture 487 2.1 (1.4, 3.1) 2.1 (1.4, 3.2)
a Gender and the presence of pneumonia were not significantly associated with
positive urine cultures in a univariate or multiple-variable models.
b Presence of urinary frequency, dysuria, hematuria, or flank or back pain.
c Meropenem, imipenem, ceftazidime, or coamoxiclav.
TABLE 2. Variables associated with in-hospital mortality (n  337)
for 755 patients with melioidosisa
Variable No. ofpatients
Univariate odds
ratio
(95% CI)
Multiple-variable
odds ratio
(95% CI)
Age 1.02 (1.006, 1.03) 1.02 (1.01, 1.03)
Diabetes 363 0.41 (0.30, 0.55) 0.36 (0.25, 0.50)
Pneumonia 362 1.7 (1.3, 2.3) 2.2 (1.6, 3.1)
Positive blood culture 487 5.0 (3.6, 7.1) 5.8 (4.0, 8.5)
Prior administration of
active antibioticsb
161 0.45 (0.31, 0.65) 0.58 (0.38, 0.89)
Negative urine culture 584 1.0 1.0
Positive urine culture 171 2.7 (1.9, 3.9) 2.0 (1.3, 2.9)
Positive spun pellet
only (103 CFU/
ml)
52 2.1 (1.2, 3.8) 1.3 (0.70, 2.5)
Positive (103 to 105
CFU/ml)
51 2.4 (1.3, 4.3) 1.5 (0.77, 2.9)
Positive (105 CFU/
ml)
68 3.7 (2.1, 6.5) 3.3 (1.8, 6.1)
b Meropenem, imipenem, ceftazidime, or coamoxiclav.
a Gender and the presence of urinary symptoms were not significantly associ-
ated with mortality in a univariate or multiple-variable models.
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fying patients with poor outcomes. This correlation is indepen-
dent of age, bacteremia, and the timeliness of antibiotic
administration. An increasing urinary bacterial concentration
was associated with an increasing mortality rate, suggesting
that the concentration in urine may be a surrogate marker for
the overall bacterial load. The lack of association between
diabetes and mortality has been noted previously (1) and may
be related to the fact that distinct factors are involved in the
acquisition of infection versus those influencing the outcome
of disease. In addition, diabetic patients may manifest mild
disease at lower levels of exposure to B. pseudomallei or may
receive appropriate antibiotics earlier for presumed melioid-
osis.
Genitourinary tract infections were previously thought to be
infrequent in Thai patients compared with other population
groups, such as those in northern Australia, where prostatic
involvement has been described for 19% of male patients (2).
During the 10-year period of this study, only 41 of 755 patients
(5%) for whom urine culture was performed had both a pos-
itive urine culture and the clinical features of urinary tract
sepsis. Since many patients did not have urine cultures per-
formed and since patients with urinary symptoms were more
likely to have cultures performed, it is likely that the true rate
of urinary involvement is lower than that described in this
study. The finding of asymptomatic bacteriuria has been con-
sidered to represent renal filtration of bacteria present in the
blood, previously termed “spillover.” We are currently inves-
tigating this assumption in a prospective study of simultaneous
quantitative urine and blood cultures.
Chronic renal failure and/or renal calculi are well-recog-
nized risk factors for melioidosis. In northeastern Thailand,
renal tubular acidosis is endemic and is strongly associated
with nephrolithiasis (4, 7). We found that patients with nondi-
abetic renal disease were more likely to have involvement of
the urinary tract, probably reflecting calculi acting as a nidus of
infection.
The observation that urinary symptoms are often absent
from melioidosis patients with positive urine cultures indicates
the utility of urine culture for the routine screening of patients
with suspected disease. For one-third of patients with bacteri-
uria, B. pseudomallei would have been missed by standard
urine culture techniques using undiluted urine since the cul-
tures were positive for the spun urinary pellet alone. This
indicates that the diagnostic sensitivity can be increased by
using concentrating techniques prior to urine culture.
In conclusion, quantitative urine culture is a simple and
inexpensive technique that has clinical utility for predicting the
outcome of melioidosis independent of blood culture positivity
and other potential confounders.
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